CLOCK and cancer: In cancer cells, CLOCK gene disruption induces NAD+ imbalance through consumption outpacing production, which sustains biosynthetic requirements while driving NAD+ depletion‐mediated aerobic glycolysis and tumor proliferation [70, 71].